327 related articles for article (PubMed ID: 123832)
41. Rapid identification of San Filippo disease (MPS III).
Kelly S; Schedlbauer L; Leikhim E
Health Lab Sci; 1978 Jul; 15(3):123-7. PubMed ID: 151669
[TBL] [Abstract][Full Text] [Related]
42. Aminosugar-containing low molecular weight acidic compounds present in urine of normal children and of patients affected by mucopolysaccharidosis type II, 3 or IV.
Calatroni A; Pallavicini G; Castellani AA
Ital J Biochem; 1974; 23(3):183-201. PubMed ID: 4214233
[No Abstract] [Full Text] [Related]
43. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
[TBL] [Abstract][Full Text] [Related]
44. Urinary amino acids in storage disorders: mucopolysaccharidosis, Gaucher's disease and metachromatic leucodystrophy.
Hultberg B; Ockerman PA; Eriksson O
Metabolism; 1969 Aug; 18(8):713-9. PubMed ID: 4241013
[No Abstract] [Full Text] [Related]
45. Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples.
Piraud M; Boyer S; Mathieu M; Maire I
Clin Chim Acta; 1993 Nov; 221(1-2):171-81. PubMed ID: 8149634
[TBL] [Abstract][Full Text] [Related]
46. Thin layer chromatography of urinary acid glycosaminoglycans as screening procedure for mucopolysaccharidoses.
Teller WM; Ziemann A
Horm Metab Res; 1969 Jan; 1(1):32-5. PubMed ID: 4258873
[No Abstract] [Full Text] [Related]
47. Enzymatic studies of urinary chondroitin sulfates in normal and systemic connective tissue disease states.
Murata K; Ishikawa T; Oshima Y
Clin Chim Acta; 1970 Apr; 28(1):213-22. PubMed ID: 4245391
[No Abstract] [Full Text] [Related]
48. Re-evaluation of heterozygous carriers of mucopolysaccharidoses.
Teller WM; Busch Ch; Bode HH
Horm Metab Res; 1969 Mar; 1(2):78-9. PubMed ID: 4258874
[No Abstract] [Full Text] [Related]
49. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
Hochuli M; Wüthrich K; Steinmann B
NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
[TBL] [Abstract][Full Text] [Related]
50. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
[TBL] [Abstract][Full Text] [Related]
51. Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome.
Kimura A; Hayashi S; Koseki M; Kochi H; Tsurumi K
Tohoku J Exp Med; 1984 Nov; 144(3):227-36. PubMed ID: 6240800
[TBL] [Abstract][Full Text] [Related]
52. [Mucopolysacchariduria and mucopolysaccharidosis].
Romano C
Minerva Pediatr; 1972 Oct; 24(35):1643-702. PubMed ID: 4264767
[No Abstract] [Full Text] [Related]
53. The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses.
Lin HY; Lee CL; Lo YT; Wang TJ; Huang SF; Chen TL; Wang YS; Niu DM; Chuang CK; Lin SP
Mol Genet Genomic Med; 2018 Nov; 6(6):982-992. PubMed ID: 30296009
[TBL] [Abstract][Full Text] [Related]
54. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans in normals and four types of mucopolysaccharidoses.
Constantopoulos G; McComb RD; Dekaban AS
J Neurochem; 1976 May; 26(5):901-8. PubMed ID: 131847
[No Abstract] [Full Text] [Related]
55. Liquid-chromatographic determination of urinary glycosaminoglycans for differential diagnosis of genetic mucopolysaccharidoses.
Kodama C; Ototani N; Isemura M; Aikawa J; Yosizawa Z
Clin Chem; 1986 Jan; 32(1 Pt 1):30-4. PubMed ID: 3079683
[TBL] [Abstract][Full Text] [Related]
56. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis.
Lin HY; Lo YT; Wang TJ; Huang SF; Tu RY; Chen TL; Lin SP; Chuang CK
Sci Rep; 2019 Jul; 9(1):10755. PubMed ID: 31341247
[TBL] [Abstract][Full Text] [Related]
57. A distinct biochemical deficit in the Maroteaux-Lamy syndrome (mucopolysaccharidosis VI).
Baron RW; Neufeld EF
J Pediatr; 1972 Jan; 80(1):114-6. PubMed ID: 4259536
[No Abstract] [Full Text] [Related]
58. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
[TBL] [Abstract][Full Text] [Related]
59. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
60. Identification and quantitation of keratan sulfate in urine.
Humbel R
Clin Chim Acta; 1974 Apr; 52(2):173-7. PubMed ID: 4275166
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
